SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
jason
Lv1
80 积分
2023-04-20 加入
最近求助
最近应助
互助留言
Personalized therapy guided by single‐cell transcriptomic analysis in relapsed and refractory KMT2A::MLLT10AML with extensive extramedullary infiltration: A case report
9小时前
待确认
Allogeneic haematopoietic stem cell transplantation for adult T‐lymphoblastic lymphoma: A real‐world multicentre analysis in China
16天前
已完结
Phase 1b safety and antitumor activity of PLM60 (pegylated liposomal mitoxantrone) in NHL
1个月前
已关闭
MINE (mesna, ifosfamide, mitoxantrone, etoposide) Chemotherapy as a Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
1个月前
已完结
[Expert consensus on vaccinations in adult patients with autoimmune rheumatic diseases in China (2023 Edition)]
1个月前
已完结
Multi-Center Phase II Study of Oral Azacitidine (CC-486) Plus CHOP As Initial Treatment for Peripheral T-Cell Lymphoma (PTCL)
1个月前
已关闭
Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia
1个月前
已关闭
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia
1个月前
已完结
Activity of Rituximab plus Cyclophosphamide, Doxorubicin/Mitoxantrone, Vincristine and Prednisone in Patients with Relapsed MALT Lymphoma
1个月前
已完结
Multi-functional nanocarriers to overcome tumor drug resistance
2个月前
已完结
没有进行任何应助
不需要了【积分已退回】
1个月前
无合适文章【积分已退回】
1个月前
doi错误
7个月前
信息错误【积分已退回】
1年前
帮大忙了
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论